Exceptions to the review requirement

An optometrist may not be required to review a patient's prescription drug monitoring program data if any of the following apply: 1. The controlled substance is prescribed or dispensed for a patient who is currently receiving hospice care. 2. The optometrist obtains a report through a board-approved risk assessment tool for health care providers that accesses patient prescription information from prescription drug monitoring program databases, analyzes the data, and provides a risk-based score that includes prescription drug monitoring program data. 3. The optometrist prescribes a controlled substance after the performance of a primary eye care procedure and no more than a seventy-two hour supply of the controlled substance is prescribed.